Double-blind crossover trial of gabapentin in SPG4-linked hereditary spastic paraplegia

K H Scheuer, K Svenstrup, P Jennum, B á Rogvi-Hansen, L Werdelin, K Fenger, J E Nielsen

10 Citationer (Scopus)

Abstract

Patients with hereditary spastic paraplegia (HSP) are often treated with antispastic drugs to relieve symptoms but documentation is lacking. In this study, gabapentin was tested in a double-blind crossover trial on a group of patients with HSP and linkage to the SPG4 locus. There was no difference between periods with gabapentin and placebo treatment in clinical assessment, self-reported parameters or paired transcranial magnetic stimulation evaluation of motor cortical excitability.

OriginalsprogEngelsk
TidsskriftEuropean Journal of Neurology
Vol/bind14
Udgave nummer6
Sider (fra-til)663-6
Antal sider4
ISSN1351-5101
DOI
StatusUdgivet - jun. 2007

Fingeraftryk

Dyk ned i forskningsemnerne om 'Double-blind crossover trial of gabapentin in SPG4-linked hereditary spastic paraplegia'. Sammen danner de et unikt fingeraftryk.

Citationsformater